Jennifer Sharpe Potter

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. pmc Characteristics of first-time alcohol treatment seekers: the COMBINE Study
    Joseph S Locastro
    Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, and Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA
    J Stud Alcohol Drugs 69:885-95. 2008
  2. pmc Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network
    Jennifer Sharpe Potter
    Division of Alcohol and Drug Abuse, Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
    J Subst Abuse Treat 38:S80-6. 2010
  3. pmc Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START)
    Jennifer S Potter
    The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
    J Stud Alcohol Drugs 74:605-13. 2013
  4. pmc Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection
    Jennifer Sharpe Potter
    Division of Alcohol and Drug Abuse, Department of Psychiatry, School of Medicine, University of Texas Health Science Center, San Antonio, 78232, USA
    Am J Drug Alcohol Abuse 37:400-7. 2011
  5. pmc Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial
    Roger D Weiss
    Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA 02478, USA
    Arch Gen Psychiatry 68:1238-46. 2011
  6. pmc Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study
    Jessica A Dreifuss
    Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA 02478, USA
    Drug Alcohol Depend 131:112-8. 2013
  7. pmc Gender differences in a clinical trial for prescription opioid dependence
    R Kathryn McHugh
    Division of Alcohol and Drug Abuse, McLean Hospital, Belmont MA 02478, USA
    J Subst Abuse Treat 45:38-43. 2013
  8. pmc Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial
    George E Woody
    Department of Psychiatry, Treatment Research Institute, University of Pennsylvania, 150 S Independence Mall W, Ste 600, Philadelphia, PA 19106, USA
    JAMA 300:2003-11. 2008
  9. pmc Impulsivity but not sensation seeking is associated with opioid analgesic misuse risk in patients with chronic pain
    Elise N Marino
    The University of Texas Health Science Center at San Antonio, 7526 Louis Pasteur, San Antonio, TX 78229, USA
    Addict Behav 38:2154-7. 2013
  10. pmc Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037)
    Madhukar H Trivedi
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 75390 9119, USA
    Am J Drug Alcohol Abuse 37:339-49. 2011

Collaborators

Detail Information

Publications11

  1. pmc Characteristics of first-time alcohol treatment seekers: the COMBINE Study
    Joseph S Locastro
    Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, and Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA
    J Stud Alcohol Drugs 69:885-95. 2008
    ....
  2. pmc Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network
    Jennifer Sharpe Potter
    Division of Alcohol and Drug Abuse, Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
    J Subst Abuse Treat 38:S80-6. 2010
    ..These findings lend further support for continued research on pain among patients with opioid dependence...
  3. pmc Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START)
    Jennifer S Potter
    The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
    J Stud Alcohol Drugs 74:605-13. 2013
    ....
  4. pmc Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection
    Jennifer Sharpe Potter
    Division of Alcohol and Drug Abuse, Department of Psychiatry, School of Medicine, University of Texas Health Science Center, San Antonio, 78232, USA
    Am J Drug Alcohol Abuse 37:400-7. 2011
    ..Selecting high-quality sites to participate is critical to recruitment, retention, and overall trial performance when conducting multi-site, community-based clinical trials of treatments for substance use disorders...
  5. pmc Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial
    Roger D Weiss
    Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA 02478, USA
    Arch Gen Psychiatry 68:1238-46. 2011
    ..No randomized trials have examined treatments for prescription opioid dependence, despite its increasing prevalence...
  6. pmc Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study
    Jessica A Dreifuss
    Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA 02478, USA
    Drug Alcohol Depend 131:112-8. 2013
    ..Prescription opioid dependence is a growing problem, but little research exists on its treatment, including patient characteristics that predict treatment outcome...
  7. pmc Gender differences in a clinical trial for prescription opioid dependence
    R Kathryn McHugh
    Division of Alcohol and Drug Abuse, McLean Hospital, Belmont MA 02478, USA
    J Subst Abuse Treat 45:38-43. 2013
    ..Thus, despite the presence of pre-treatment gender differences in this population, once the study treatment was initiated, women and men exhibited similar opioid use outcomes...
  8. pmc Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial
    George E Woody
    Department of Psychiatry, Treatment Research Institute, University of Pennsylvania, 150 S Independence Mall W, Ste 600, Philadelphia, PA 19106, USA
    JAMA 300:2003-11. 2008
    ..The usual treatment for opioid-addicted youth is detoxification and counseling. Extended medication-assisted therapy may be more helpful...
  9. pmc Impulsivity but not sensation seeking is associated with opioid analgesic misuse risk in patients with chronic pain
    Elise N Marino
    The University of Texas Health Science Center at San Antonio, 7526 Louis Pasteur, San Antonio, TX 78229, USA
    Addict Behav 38:2154-7. 2013
    ..As such, these findings suggest that additional exploration of this potential risk factor is warranted...
  10. pmc Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037)
    Madhukar H Trivedi
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 75390 9119, USA
    Am J Drug Alcohol Abuse 37:339-49. 2011
    ..Abstinence is the most desirable treatment outcome although a wide variety of other endpoints have been used...
  11. ncbi request reprint Chronic Pain Perspectives: How to avoid opioid misuse
    Jennifer Sharpe Potter
    The University of Texas Health Science Center at San Antonio, TX, USA
    J Fam Pract 62:S2-7. 2013
    ..These practical strategies will help you to identify and monitor the risk of opioid analgesic misuse...